Lantheus Holdings, Inc. (BIT:1LNTH)
73.56
+1.42 (1.97%)
At close: Jun 10, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2018 - 2020 |
Other Radiopharmaceutical Oncology | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Radiopharmaceutical Oncology Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
DEFINITY | 320.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
DEFINITY Growth | 11.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TechneLite | 93.48M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
TechneLite Growth | 6.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Precision Diagnostics | 23.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Precision Diagnostics Growth | 2.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Strategic Partnerships and Other | 42.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Strategic Partnerships and Other Growth | -14.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PYLARIFY | 1.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PYLARIFY Growth | 15.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product | 1.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product Growth | 13.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
License and Royalty | 14.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
License and Royalty Growth | -43.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|